Trade Summary

2 days ago, Hamilton James C, serving as Chief Medical Officer at Arrowhead Pharmaceuticals, Inc. (ARWR), sold 10,000 shares at $75.00 per share, for a total transaction value of $750,000.00. Following this transaction, Hamilton James C now holds 226,958 shares of ARWR.

This sale represents a 4.00% decrease in Hamilton James C's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, April 23, 2026 and publicly disclosed via SEC Form 4 filing on Friday, April 24, 2026, 1 day after the trade was made.

Arrowhead Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.